Aster CMI Hospital, Indian Institute of Science (IISc) launch Artificial Intelligence (AI) Lab
Bengaluru(Press Release): In keeping with its commitment to bring quality healthcare using the latest medical technology, Aster CMI Hospital in association with the Indian Institute of Science (IISc) launched an Artificial Intelligence (AI) lab today. The Aster-AI lab is a collaborative lab, set up with the aim to build cutting edge AI products in the healthcare domain and bridge the gap between clinical medicine and technology by training healthcare professionals in AI. Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare, Dr. Lokesh B, Consultant Neurology, Aster CMI Hospital and Dr. Phaneendra K Yalavarthy, Professor of Medical Imaging, Department of Computational and Data Sciences, IISc were present during the launch.
Artificial Intelligence (AI) is an interdisciplinary science creating a paradigm shift in virtually every sector of the industry. AI uses data with machine learning and deep learning algorithms to imitate the way that humans learn, gradually improving its accuracy. These data-driven AI applications have been continuing to change the way doctors solve clinical problems. The current possibilities and capabilities of AI in medicine can enable quicker diagnosis and lower healthcare costs.
Speaking on the need and how technology is transforming the healthcare system in India, Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare, said: “At Aster, we have always believed in staying closely connected with the pulse of our patients and our people to be able to adapt as per their needs and stay ahead of the curve. We have been at the forefront of adopting digitization, technology and innovation into our core operations which is now essential to support patients as per their needs. With the use of AI, doctors and medical providers will now be able to deliver more accurate diagnosis in the fastest possible time which can aid the treatment journey. Also, AI would be a big leap towards predictive and proactive data analytics which will improve preventive care recommendations for patients. We are really glad to partner with IISc, which will open doors for healthcare professionals to undertake research and better utilize AI tools to understand their patient’s disease patterns and improve treatment outcomes significantly.”
Commenting on the collaboration, Dr. Lokesh B, Consultant Neurology, Aster CMI Hospital, said: “We are glad to associate with IISc to launch the Aster-AI lab. This lab will be hosted at Aster CMI to enable faster translation into the clinical care system. This collaboration is only a start; future scope includes exchange of personnel as well as joint workshops for increased cooperation in making AI in medicine more effective both for clinicians as well as patients. This is the first collaborative lab in the clinical environment with an aim to perform impactful as well as translatable research work in the space of AI in medicine.”
Prof. Phaneendra K Yalavarthy has been instrumental in setting up the lab by providing the computational infrastructure and expertise. IISc, with its expertise in the development of AI methods, has become the natural collaborator with Aster CMI, which has the clinical expertise, to aide, translate, and validate the developed AI algorithms for clinical use.
Expressing his excitement to have associated with Aster CMI Hospital, Dr. Phaneendra K Yalavarthy, Professor of Medical Imaging, Department of Computational and Data Sciences, IISc, said: “Artificial Intelligence (AI)-powered medical technologies have been rapidly evolving and have become powerful adjunct tools in clinical practise. The broad spectrum of digital medicine, especially to enable the 4P model of medicine (Predictive, Preventive, Personalized, and Participatory) involves natural collaboration between academic institutions and medical institutions. This Artificial Intelligence lab is a collaborative effort to develop these AI technologies in the hospital settings, such that the translation to clinic will be seamless. The initial focus of this collaborative lab will be in neurology and will later be expanded to other clinical specialities. We are thankful to Aster CMI for providing space to establish this lab at their hospital to enable co-development of some of these AI technologies for healthcare. This collaborative lab will enable the development of highly impactful research and technologies with a focus on translation to the bedside.”
Aster CMI will be working with Prof. Phaneendra and his team on ‘Development of Deep Learning Methods for Automated Tracking and Segmentation of Nerves in Ultrasound Images’. Dr. Sriram Ganapathy, Associate Professor, Department of Electrical Engineering, IISc has been collaborating on ‘Automatic Acute Stroke Symptom Detection Using Mobile Health Technologies’ and also on audio analytics in neurological disorders. These initial projects have a direct impact on the current clinical practise in neurosciences. The problem-solving requires deep technical and clinical knowledge, which the Aster-AI lab aims to bring together.
About Aster DM Healthcare
Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through our hospitals, clinics and pharmacies. We have over 19,800+ plus dedicated employees across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands.
About IISc - The Indian Institute of Science (IISc) was established in 1909 by a visionary partnership between the industrialist Jamsetji Nusserwanji Tata, the Mysore royal family, and the Government of India. Since its inception, the Institute has laid a balanced emphasis on the pursuit of basic knowledge in science and engineering and applying its research findings for industrial and social benefit. In 2018, IISc was selected as an Institution of Eminence (IoE) by the Government of India, and it consistently figures among the top Indian institutions in world university rankings. According to the QS world university ranking 2022, IISc has secured the top place in the world in the citations per faculty metric, which is a measure of research impact.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Rupee hits record low of 96.14/USD, settles at fresh closing low of 95.86/USD
Mumbai (PTI): The Indian rupee crashed below the 96/USD mark on Friday before closing at an all-time low of 95.86 (provisional) against the US dollar as elevated crude oil prices and inflation concerns added to the downside pressure on the rupee.
Rupee has registered over 6 per cent losses so far this year, and in the past six trading sessions, it has depreciated nearly 2 per cent as Iran war risk escalation pushed crude oil prices higher. The dollar index moved northwards after strong US retail sales and stable labour market data reduced expectations of aggressive Federal Reserve rate cuts.
Forex traders said global uncertainties, relatively high valuations, and the lack of AI-led investment opportunities have weighed on capital flows.
Moreover, weak net FDI inflows are likely to exert pressure on the balance of payments, while rising crude oil prices stoke inflation worries.
At the interbank foreign exchange, the rupee opened at 95.86, then slumped to a record low of 96.14 in intraday trade, registering a fall of 50 paise from its previous close.
The USD/INR pair finally settled at 95.86 (provisional) against the US dollar, registering a fall of 22 paise from its previous close, helped by likely RBI intervention.
On Thursday, the rupee weakened to a fresh record low of 95.96 before closing with a marginal gain of 2 paise at 95.64 against the US dollar.
Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, was trading at 99.15, higher by 0.34 per cent.
Brent crude, the global oil benchmark, was trading up 3.14 per cent at USD 109.04 per barrel in futures trade.
On the domestic equity market front, Sensex fell 160.73 points to settle at 75,237.99, while Nifty declined 46.10 points to 23,643.50.
Foreign Institutional Investors turned net buyers, purchasing equities worth Rs 187.46 crore on Thursday, according to exchange data.
Meanwhile, the country's exports in April rose by 13.78 per cent to USD 43.56 billion despite global challenges, Commerce Secretary Rajesh Agrawal said on Friday.
Imports grew 10 per cent year-on-year to USD 71.94 billion in April. The trade deficit during the month stood at USD 28.38 billion.
"We expect the rupee to trade with a negative bias on elevated crude oil prices and inflation concerns. Strong dollar and FII outflows may also weigh on the rupee. However, any intervention by the RBI and hiking of import duty on gold and silver may support the rupee at lower levels. USD-INR spot price is expected to trade in a range of 95.60 to 96.20," said Anuj Choudhary, Research analyst at Mirae Asset ShareKhan.
Chinese President Xi Jinping and his US counterpart Donald Trump on Friday hailed their talks as "historic" and "landmark", as the American leader wrapped up his three-day visit on a high note, but no deals on any contentious issues were announced.
Both Presidents, who held several rounds of talks covering a range of global issues, including the Iran war and bilateral trade frictions, concluded their discussions with a private meeting at Zhongnanhai, the well-guarded compound in Beijing where top leaders reside.
